Ibritumomab Tiuxetan and Tadalafil Tablets (Pulmonary Hypertension)
Determining the interaction of Ibritumomab Tiuxetan and Tadalafil Tablets (Pulmonary Hypertension) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: tadalafil
Brand name: Adcirca, Cialis, Alyq
Synonyms: Tadalafil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Tafamidis
- Ibritumomab Tiuxetan-Tafamidis, Tafamidis Meglumine
- Ibritumomab Tiuxetan-Tafenoquine
- Ibritumomab Tiuxetan-Tafenoquine (Malaria Prevention)
- Ibritumomab Tiuxetan-Tafenoquine (Prevention of Malaria Relapse)
- Ibritumomab Tiuxetan-Tafenoquine Succinate (Arakoda)
- Tadalafil Tablets (Pulmonary Hypertension)-Ibrutinib
- Tadalafil Tablets (Pulmonary Hypertension)-Ibrutinib Capsules
- Tadalafil Tablets (Pulmonary Hypertension)-Ibrutinib Tablets
- Tadalafil Tablets (Pulmonary Hypertension)-Ibu
- Tadalafil Tablets (Pulmonary Hypertension)-IBU Tablets
- Tadalafil Tablets (Pulmonary Hypertension)-Ibu-2